Mechanisms underlying the effects of amphetamine on particulate PKC activity
- 3 November 2003
- Vol. 51 (2), 128-139
- https://doi.org/10.1002/syn.10289
Abstract
Amphetamine stimulates particulate protein kinase C (PKC) activity that is associated with the outward‐transport of dopamine (DA) (Giambalvo [2003] Synapse 49:125–133). This stimulatory effect requires intracellular calcium ([Ca]i) and endogenous DA and when DA release is diminished, the inward‐transport of amphetamine inhibits PKC activity. This study examines the mechanisms involved. It was found that synaptoneurosomes incubated with amphetamine showed a dose‐dependent increase in phospholipase C and A2 activities. Furthermore, pretreatments with the phospholipase C inhibitor D609 or the phospholipase A2 inhibitors quinacrine or p‐bromophenacylbromide attenuated the amphetamine‐induced increase in PKC activity. This suggests that both phospholipases were essential for the amphetamine‐induced increase in PKC activity. The Na/Ca antiporter was also involved, since pretreatment with amiloride or benzamil attenuated the amphetamine‐induced increase in PKC activity. Since these drugs by themselves increased PKC activity, the return to basal activity after addition of amphetamine suggests that, in the absence of Na/Ca exchange, amphetamine had an inhibitory effect on PKC activity. This inhibitory effect might be due to the activation of phospholipase A2 through an increase in intracellular pH induced by amphetamine. This was supported by the finding that pretreatment with dimethylamiloride, an inhibitor of the Na/H antiporter that increases intracellular [H+], attenuated the effects of amphetamine on PKC activity. Other drugs that decrease intracellular [H+] (ammonia, monensin) also inhibited PKC activity without Ca. In contrast to amphetamine, monensin had no effect on PKC activity with Ca. This could be related to its large differential effects on phospholipase A2 vs. phospholipase C activity. Thus, the monensin‐mediated decrease in PKC activity seen without Ca was partially attenuated by pretreatment with quinacrine. Furthermore, when Na/Ca antiporter was inhibited with benzamil, monensin inhibited PKC activity. These results suggest that amphetamine, as well as monensin, may have dual effects on PKC activity, a Ca‐dependent stimulatory effect via phospholipase C, and an inhibitory effect via phospholipase A2. Synapse 51:128–139, 2004.Keywords
This publication has 49 references indexed in Scilit:
- Effects of fenfluramine and antidepressants on protein kinase C activity in rat cortical synaptoneurosomesSynapse, 2003
- Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomesSynapse, 2003
- Inhibition of Transferrin Recycling and Endosome Tubulation by Phospholipase A2 AntagonistsJournal of Biological Chemistry, 2001
- Relationship between dopamine agonist stimulation of inositol phosphate formation and cytidine diphosphate–diacylglycerol accumulation in brain slicesBrain Research, 1999
- Amphetamine increases the phosphorylation of neuromodulin and synapsin I in rat striatal synaptosomesSynapse, 1997
- Regulation of Phosphoinositide Phospholipases by Hormones, Neurotransmitters, and Other Agonists Linked to G ProteinsAnnual Review of Pharmacology and Toxicology, 1996
- Relationship between the thyroid hormone transport system and the Na(+)- H+ exchanger in cultured rat brain astrocytesEndocrinology, 1995
- Identification and Purification of Calcium‐Independent Phospholipase A2 from Bovine Brain CytosolJournal of Neurochemistry, 1992
- Influence of Bradykinin on Diacylglycerol and Phosphatidic Acid Accumulation in Cultured Bovine Adrenal Chromaffin CellsJournal of Neurochemistry, 1991
- Measurement of arachidonic acid liberation in thrombin-stimulated human platelets. Use of agents that inhibit both the cyclooxygenase and lipoxygenase enzymesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985